Cargando…
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
Human epidermal growth factor receptor-2 (HER-2) is a well-established target for anticancer anticancerprecision medicine in humans. A HER-2 homologue with 92% amino acid identity has been described in canine mammary tumors, which whichis termed here as ‘dog epidermal growth factor receptor-2 (DER-2...
Autores principales: | Fazekas, Judit, Fürdös, Irene, Singer, Josef, Jensen-Jarolim, Erika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038860/ https://www.ncbi.nlm.nih.gov/pubmed/27698788 http://dx.doi.org/10.3892/ol.2016.5001 |
Ejemplares similares
-
Translating clinical trials from human to veterinary oncology and back
por: Fürdös, Irene, et al.
Publicado: (2015) -
The domestic dog: man's best friend in the genomic era
por: Boyko, Adam R
Publicado: (2011) -
Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474
por: Fazekas, Judit, et al.
Publicado: (2017) -
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
por: Petricevic, Branka, et al.
Publicado: (2013) -
Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer
por: Jensen-Jarolim, Erika, et al.
Publicado: (2015)